Axon Enterprise, Inc $AXON Stock Holdings Lifted by EFG Asset Management North America Corp.

EFG Asset Management North America Corp. increased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 17.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,701 shares of the biotechnology company’s stock after buying an additional 1,918 shares during the quarter. Axon Enterprise accounts for about 1.5% of EFG Asset Management North America Corp.’s portfolio, making the stock its 9th largest position. EFG Asset Management North America Corp.’s holdings in Axon Enterprise were worth $10,511,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. TCTC Holdings LLC grew its stake in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares during the last quarter. Banque Transatlantique SA purchased a new stake in Axon Enterprise during the 1st quarter valued at about $31,000. Flaharty Asset Management LLC purchased a new stake in Axon Enterprise during the 1st quarter valued at about $33,000. Hemington Wealth Management lifted its holdings in shares of Axon Enterprise by 70.8% in the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 17 shares during the period. Finally, Whipplewood Advisors LLC lifted its holdings in shares of Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after buying an additional 27 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

AXON stock opened at $706.13 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The business has a 50 day simple moving average of $729.01 and a 200-day simple moving average of $736.07. The firm has a market capitalization of $55.43 billion, a PE ratio of 174.35, a price-to-earnings-growth ratio of 29.49 and a beta of 1.41. Axon Enterprise, Inc has a 1 year low of $433.97 and a 1 year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, November 4th. The biotechnology company reported $1.17 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.46). The business had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s revenue was up 30.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.45 earnings per share. Axon Enterprise has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AXON. Weiss Ratings reissued a “hold (c)” rating on shares of Axon Enterprise in a report on Wednesday, October 8th. Northland Securities set a $800.00 price objective on Axon Enterprise in a report on Tuesday, August 5th. UBS Group reissued a “neutral” rating and issued a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective for the company in a report on Tuesday, August 5th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $870.00 price objective on shares of Axon Enterprise in a report on Wednesday, September 24th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $841.64.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This represents a 5.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua Isner sold 15,919 shares of the company’s stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 4.40% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.